1. FRI0014 Il-21 is upregulated in sle and promotes tfh-mediated b cell maturation and ig production. (23rd January 2014) Authors: Cox, J. H.; Hussell, S. W.; Thomas, E. P.; Wu, R.; Valliant-Saunders, K.; Smith, P.; Peng, S. L.; Blumberg, H.; Levin, S. D.; Lundsgaard, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0196 A DOUBLE BLIND, PLACEBO CONTROLLED, SINGLE ASCENDING DOSE (SAD) AND MULTIPLE ASCENDING DOSE (MAD) STUDY OF ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, IN HEALTHY VOLUNTEERS (HV). (2nd June 2020) Authors: Yang, J.; Hillson, J.; Lickliter, J.; Manjarrez, K.; Tercero, A.; Wiley, J.; Means, G.; Sanderson, R.; Carley, K.; Peng, S. L. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1040 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0222 B CELL MODULATORY VARIANT TNF RECEPTOR DOMAINS (VTDS) IDENTIFIED BY DIRECTED EVOLUTION TO INHIBIT BAFF AND APRIL, ALONE OR COMBINED WITH VARIANT IG DOMAINS (VIGD™) THAT INHIBIT T CELL COSTIMULATION, FOR THE TREATMENT OF SEVERE AUTOIMMUNE AND/OR INFLAMMATORY DISEASE. (2nd June 2020) Authors: Dillon, S. R.; Evans, L. S.; Rixon, M. W.; Kuijper, J.; Demonte, D.; Lewis, K. E.; Levin, S.; Kleist, K.; Mudri, S.; Bort, S.; Bhandari, J.; Ahmed-Qadri, F.; Yang, J.; Seaberg, M. A.; Wang, R.; Sanderson, R.; Wolfson, M. F.; Hillson, J.; Peng, S. L.; Swiderek, K. M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗